Pherecydes Pharma is proud to announce the publication of it first scientifique paper in: Bioscurity and Bioterrorism: Biodefense Strategy, Practice and Science.

French and American biotech companies met on March 15 and 17 2010 to see how they can collaborate to develop effective therapeutics and diagnostics to combat infectious diseases. MRSA and other bacterial threats have been a few of the hot topics.

For the third time in less than 2 years Pherecydes Pharma is presenting at a biofense conferences, in the USA.